Gastroenterology

FOXO1 overexpression and loss of pSerine256-FOXO1 expression predicts clinical outcome in esophageal adenocarcinomas




FOXO1 overexpression and loss of pSerine256-FOXO1 expression predicts clinical outcome in esophageal adenocarcinomas

Source link




Related posts

Black-White Cancer Mortality Gap Decreasing in Some Age Groups

Newsemia

Modified-FOLFIRINOX Beneficial in Resected Pancreatic Cancer

Newsemia

Development and Validation of a Simplified Magnetic Resonance Index of Activity for Crohn’s disease

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy